Dennis E. van Epps
Keine laufenden Positionen mehr
Profil
Dr. Van Epps has served as our Vice President, Research since November 2001.
From 2000 to 2001, Dr. Van Epps served as Vice President of Research and Development, and from 1997 to 2000 as Vice President, Research, and an officer at Nexell Therapeutics, a publicly-traded biotechnology company.
From 1993 to 1997, Dr. Van Epps served as Vice President of Research for Baxter Healthcare Corporation's Immunotherapy Division and as a Director at the Applied Cell Biology Center from 1988 to 1993.
From 1985 to 1988, Dr. Van Epps was a Professor of Medicine and Pathology at the University of New Mexico School of Medicine.
Prior to 1985 he held positions as Associate Professor of Medicine and Pathology and Assistant Professor of Medicine and Microbiology at the same medical school.
Dr. Van Epps obtained his postdoctoral training in immunology in the Department of Medicine at the University of New Mexico and has published over 135 manuscripts in the fields of immunology, cell therapy, inflammation and stem cell biology.
He is also an inventor on nine patents in the fields of human cell selection technology, stem cell culture and cell therapy.
Dr. Van Epps received a B.S.
degree in zoology from Western Illinois University and a Ph.D.
in microbiology and immunology from the University of Illinois Medical School in Chicago, Illinois.
Ehemalige bekannte Positionen von Dennis E. van Epps
Unternehmen | Position | Ende |
---|---|---|
CancerVax Corp. | Technik-/Wissenschafts-/F&E-Leiter | 09.05.2006 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Technik-/Wissenschafts-/F&E-Leiter | 15.04.2006 |
Ausbildung von Dennis E. van Epps
Western Illinois University | Undergraduate Degree |
University of Illinois | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
CancerVax Corp. | Commercial Services |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |